Viewing Study NCT07001995


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-02-20 @ 7:29 PM
Study NCT ID: NCT07001995
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-03
First Post: 2025-05-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module